GRM5 and central nervous system cancer: However, under hypoxia, the treatment with the mGluR5 MPEP reduced the viability of glioma cells compared to the treatment with CPCCOE and increased the expression of mitochondrial respiratory function genes, such as PGC-1a and PGC-1b (75).